edible cannabis
  • Rubicon Organics (ROMJ) expects its Wildflower CBD Relief Sticks and Wildflower CBD Cool Sticks to be available to consumers in four provinces in April
  • The company has purchase orders from distributors in Ontario, British Columbia, Alberta and Saskatchewan
  • Rubicon announced in September it was licensed to manufacture and distribute Wildflower-branded products in Canada
  • Wildflower CBD Relief Sticks and CBD Cool Sticks are best-sellers in the U.S.
  • Rubicon Organics is up 1.93 per cent on the day, with shares of the company trading at C$3.70 at 11:50 am ET

Rubicon Organics’ Wildflower CBD Relief Sticks and Wildflower CBD Cool Sticks will be available to consumers in four provinces in April.

The company has purchase orders from distributors in Ontario, British Columbia, Alberta and Saskatchewan.

Rubicon Organics announced a brand licensing agreement with Wildflower Brands in September, 2020 where it would manufacture and distribute Wildflower-branded products in Canada.

The Relief Stick’s and Cool Stick’s all-natural formulations are Wildflower Brand’s best-sellers in the United States and international markets. As a result, Rubicon believes these products will be well received by Canadian customers and buyers alike.

“Proven and trusted, Wildflower CBD topicals feed the increasing demand for non-psychoactive cannabis products for integration into our consumers’ daily routines. We believe this launch will drive Rubicon’s profitability by increasing our category offering of quality cannabis products,” said Rubicon CEO Jesse McConnell.

Rubicon Organics aims to be a global brand leader in organic cannabis products. Its wholly-owned subsidiary Rubicon Holdings Corp is a licensed producer which cultivates, processes and sells organic certified, sustainably produced, super-premium cannabis products.

Rubicon Organics is up 1.93 per cent on the day, with shares of the company trading at C$3.70 at 11:50 am ET.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.